Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products

, , , , , ,
The American Journal of Managed Care, February 1996, Volume 2, Issue 2